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SARAbstract Human body is constantly generating free radicals, which causes oxidative stress. Despite
naturally occurring antioxidant systems in human body, free radicals cause lipid, proteins and DNA
oxidation. New antioxidants are still urgent as well as their mechanisms of action should be
explained. In this study, we investigated the mechanism by which eleutherosides B, E and E1
may act as antioxidants, identified eleutherosides in Eleutherococcus lasiogyne and Eleutherococcus
giraldii, and explained in vitro the absorption of eleutheroside E1 based on passive transport. The
DPPH* and DB-HPTLC tests were used to assess the antioxidant activity. Of the three eleuthero-
sides, only eleutheroside E1 exhibited a strong anti-DPPH* activity (EC50 37.03 lg/mL; 63 mMol)
compared to the raw extracts (EC50 170 and 180 lg/mL for E. lasiogyne and E. giraldii). This activ-
ity was also confirmed by the DB-HPTLC autography technique. According to Załuski’s hypoth-
esis, the antioxidant mechanism of eleutheroside E1 is based on the complexation of DPPH*
molecule with its aryl radical. During this reaction, the aryl radical of eleutheroside E1 (E1*) and
DPPHH are created. Next, the aryl radical (E1*) is complexed with another DPPH* molecule. Addi-
tionally, the aryl radical can be stabilized by the presence of the methoxy groups in the aromatic
ring, which increases its antioxidative action. The HPTLC-identification of extracts showed the
presence of eleutherosides B, E and E1 in both species. The PAMPA test coupled with LC/MS
detection showed a low permeability of eleutheroside E1 across artificial membrane. Because
eleutherosides belong to the polyphenols, the TPC and TFC were quantified. The TPC and TFC
HPTLC-profiling of eleutherosides 521varied from 51.4 to 49.3 mg/g dry extract for TPC, and from 5.73 to 4.91 mg/g dry extract for TFC,
for E. giraldii and E. lasiogyne, respectively. In conclusion, eleutheroside E1 in its pure form could
be a chemopreventive ingredient of new pharmacological or dietary products, stimulating the
GALT. These findings can explain partially the adaptogenic activity of eleutheroside E1 on the
GALT, which has been still unknown.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Human body is constantly generating free radicals, which
causes oxidative stress. Several factors such as drugs, chlori-
nated compounds, and deficiency of natural antioxidants,
tobacco and pollution may increase the ratio of free radicals.
Despite naturally occurring antioxidant systems in human
body, free radicals cause lipid, proteins and DNA oxidation.
These damages at the molecular level may influence the etiol-
ogy of diseases, such as cancer, atherosclerosis, diabetes, neu-
rodegenerative disorders and aging. Some evidences indicate
that the diet rich in antioxidants may be protective against
abovementioned diseases (Ahmed et al., 2013; Cooke, 2012;
Cieśla et al., 2012). One of the special sources of antioxidants
is plants belonging to the Eleutherococcus Maxim. genus
(native to China, Korea, Japan and Russia). It is believed that
the chemical compounds are eleutherosides A, B, B1, E, E1, I,
K, L and M, which are the glycosides of coumarins (eleuthero-
side B1), lignans (eleutheroside B, E, E1), sterols (eleutheroside
A), and triterpenic acids (eleutheroside I, K, L, M). Eleuthero-
side B and E are responsible for the pharmacological effect, for
the sum of which the standardization of products with Eleuthe-
rococcus extracts is carried out (Załuski et al., 2010; Park et al.,
2006; Polish Pharmacopoeia VIII, 2008). It is thought, these
two compounds are responsible for adaptogenic properties of
Eleutherococcus spp. The concept of adaptogen was first used
by a Soviet scientist, dr Nikolai Lazarev, who was researching
substances which produced a ‘‘state of nonspecific resistance”.
Adaptogens act as drugs via increasing non-specific resistance
of the body. Other studies showed that extracts from E. senti-
cosus added as adjuvants to vaccines for the prevention and/or
treatment of microbial, viral infections and/or cancer, may
affect the expression of proteins associated with immune
response to microbial infection, viral infection and/or cancer.
Some authors believe that eleutheroside B and E are responsi-
ble for the adaptogenic activity of Eleutherococcus, whereas
others believe it is the result of the synergistic action of all
the constituents.
Pharmacokinetic studies have demonstrated that these
eleutherosides are very well absorbed in the human intestines,
with a peak plasma concentration occurring at 30 min. The
eleutherosides may be absorbed by the cell by means of active
glucose and galactose carriers. Some studies have shown that
the accumulation time of eleutheroside B is between 2 and
4 h. The experimental results demonstrated that eleutherosides
B and E are cumulated in the plasma, heart, kidney and liver.
Concentrations of eleutheroside B and E were higher in the
liver and kidney, which demonstrates that both eleutherosides
B and E are metabolized and excreted primarily by the liver
and kidneys (Feng et al., 2006). The adaptogenic activity of
eleutheroside E1 and its pharmacokinetic parameters remainstill unknown. In addition its distribution in Eleutherococcus
spp. is poorly investigated.
Previous phytochemical studies on E. giraldii have reported
the presence of eleutherosides E and B4, isofraxidin, b-
sitosterol, hederagenin glycosides, sesquiterpenes, polysaccha-
rides, hyperoside, syringing, syringaresinol and lipid acids.
Besides, in the stem bark of E. giraldii, chlorogenic, caffeic
and protocatechuic acids were identified, as well as thymine,
uracil, xanthine, adenine, hypoxanthine, adenosine, lirioden-
drin and allantoin (Yuan et al., 2009; Wang et al., 2005;
Dong-Liang et al., 1994; Li et al., 2009; Zhao and Yuan,
1991; Liu et al., 2007; Wang et al., 2005).
These constituents play key functions in ill-health preven-
tion and in the treatment of many diseases. It has been
reported that they have antiinflammatory, immunostimulative,
anticancer and hepatopreventive properties; an inhibitory
effect on COX-1 and COX-2 was also observed. It is used in
the treatment of anemia and rheumatoid arthritis. The tea
from E. giraldii can resist hyperlipemia, and inhibit absorption
of cholesterol and the growth of tumor cells. In addition, the
tea has a protecting effect on the liver. The polysaccharides
can be used to treat neutropenia, thrombocytopenia and viral
infectious diseases (Wang et al., 1992; Deng et al., 1994).
Keeping in mind their rich biological activity and long-term
use by the Asian, we have decided to evaluate the quality of
Eleutherococcus species cultivated in Polish climate conditions
as a raw herbal material. The chemical compounds and biolog-
ical activity of plants depend on the geographical zone of the
growth. These species are cultivated at the botanic garden in
Rogów, which lies in the Central Polish Lowlands region with
geographic data such as 51490N and 19530E. The average,
long-term temperature is 20.1 C, which classified the garden
to the 6bth sub-climate (according to USDA Frost Hardiness
Zones) and to the second zone according to the Kórnik cate-
gory. These plants are grown on the acidic, luvic, and sandy
soils (Tumilowicz and Banaszczak, 2007).
Studies on eleutherosides are important for drug discovery,
design and clinical application. In this report we aimed at
searching new antioxidants in E. giraldii and E. lasiogyne, as
well as we suggested the hypothetical mechanism of the anti-
radical action of eleutheroside E1 and B. The PAMPA test
of eleutheroside E1 with LC/MS detection was also performed.
From the pharmacological point of view, an in vitro explana-
tion of the antiradical mechanism of chemical compounds is
needed because in vivo experiments are sometimes unable to
clearly explore the mechanism of their action. Of course, the
impact of absorption, distribution and metabolism within the
body cannot be reflected through in vitro testing, but to explain
the causes of all changes, in vitro tests must also be performed.
Because the therapeutic effect of Eleutherococcus spp. depends
on the presence of the eleutherosides as active ingredients, one
522 D. Załuski et al.of the objectives of this work was HPTLC-the identification of
eleutheroside B, E and E1.
2. Materials and methods
2.1. Materials
The standards of eleutherosides B, E and E1 were obtained
from ChromaDex (Santa Ana, CA). 1.1-diphenyl-2-picryl-
hydrazyl (DPPH*), ascorbic acid, and L-a-
phosphatidylcholine were purchased from Sigma–Aldrich.
Methanol, ethanol, 2,4-DNPH and FeCl3 were obtained from
POCH (Lublin, Poland). All others reagents were of analytical
grade.
2.2. Plant material
The roots of E. giraldii (Harms) Nakai and E. lasiogyne
(Harms) S.Y. Hu were obtained from arboretum in Rogów
(Poland). The roots were collected in October 2013. Voucher
specimens were deposited at the Department of Pharmacog-
nosy, Jagiellonian University of Cracow, Poland marked as
EG-011 and EL-02.
2.3. Accelerated solvent extraction (ASE)
The air-dried and powdered roots (2 g) from E. giraldii and
E. lasiogyne were placed in 5 mL extraction cell with 3 g of
neutral silica gel. The ASE cell was placed into ASE for extrac-
tion process (Dionex ASE 159). During the extraction process,
75% ethanol was delivered into the extraction cell. Pressure
(1000 psi) was applied to maintain the solvent in its liquid
state. The extraction process was repeated three times using
after 18 mL 75% ethanol. The extraction temperature was
40 C, the extraction time was 15 min. Following extraction,
the extract containing the target analytes was purged from
the cell using nitrogen into a collection vial for analysis. After
the three extraction cycles 54 mL each of extracts was
obtained. The solvents were evaporated under reduced pres-
sure at 45 C and the residue was subjected to lyophilization
(Labconco Freezone 1).
2.4. Solid phase extraction (SPE)
The extracts were purified by SPE according to Załuski et al.
(2011). Each extract dissolved in 2 mL 75% ethanol was
applied to a Bakerbond SPETM Octadecyl C18 microcolumns
(500 mg, 3 ml; J.T. Baker, Phillipspurg, NJ, USA) previously
activated with 2 mL 99.8% ethanol, then with 2 mL distilled
water, and finally with 2 mL 75% ethanol. After the applica-
tion of the sample solution the target analytes were eluted with
4 mL 75% ethanol. Collected eluates were concentrated in a
nitrogen stream and subjected to lyophilization. Samples pre-
pared in this underwent chromatographic analysis.
2.5. DPPH assay
The ability of the extracts to scavenge DPPH free radicals was
determined by the modified method of Brand-Williams et al.
(1995). The methanol solvents of the extracts at the followingconcentrations: 0.1; 0.5; 1.0; 1.5 mg/mL were used. A 40 lL
sample of extract was mixed with 160 mL of methanol solution
of DPPH* (0.2 mmol/L). Absorbance was measured at the
wavelength of 515 nm at 1, 5, 10, 30, 60, 90 min on a multide-
tection BIOTEK spectrophotometer. Pure methanol was used
as a control sample. Antioxidant activity was expressed as a
percentage of inhibition calculated according to the following
formula:
% inhibition ¼ ½ðACð0Þ  AAðtÞÞ=ACð0Þ  100
where AC(0) – absorbance of the control sample at 0 time, AA(t)
– absorbance of the experimental sample measured after 5 min.
Ascorbic acid was used as a positive control (12.5; 25; 50;
75 lg/mL) and ethanolic solutions of eleutheroside B, E, E1
(0.1; 0.5; 1.0; 2.0 mg/mL). Next, EC50 value was assayed.
Every assay was performed in triplicates.
2.6. PAMPA test with LC/MS detection
The PAMPA test was performed according to the modified
method of Załuski et al. (2016). Permeation experiments of
eleutheroside E1 and verapamil (as a positive control) were
carried out in hydrophobic PVDF 96-well filter plates (Milli-
pore, Molsheim, France). Each well of the donor plate was
coated with 1% (v/v) liquid membrane (L-a-
phosphatidylcholine) dissolved in n-dodecane for 20 min to
completely evaporate the solvent. Next, in each well of donor
plate, 150 lL 40 lM of eleutheroside E1 in 0.1 M PBS pH 7.4
was transferred. In each well of acceptor plate, 300 lL 0.1 M
PBS/4.7% MeOH acceptor solution was transferred and cov-
ered by the donor plate, creating a PAMPA sandwich. Each
substance was measured in triplicates at iso-pH conditions
(the same pH value in donor and receptor compartment).
The donor plate was covered to prevent evaporation and the
whole system set up to interact with the vibratory mixer
(500 rpm). After 4 h, PAMPA sandwich was removed from
the mixer and vibration, and the concentration of the investi-
gated substances in the donor and receptor compartments were
quantified from an appropriate calibration line using LC–MS.
Before LC/MS analysis, the donor solution was diluted four
times 0.1 M PBS/4.7% MeOH. A UltiMate 3000RS/DAD
Dionex system equipped with a binary gradient solvent pump,
a degasser, an autosampler and column oven connected to
amaZon SL Bruker Daltonics Mass spectrometer was used.
Chromatographic separations were carried out at 25 C, on
an Ascentis Express C18 column (2.1  50 mm, 2.7-lm parti-
cle size; Sigma–Aldrich) with a mobile phase consisting of
water containing 0.1% HCOOH (solvent A) and ACN con-
taining 0.1% HCOOH (solvent B), using 10 lL injections.
The flow rate was 1 mL min1 and the gradient was as follows:
0–0.5 min – 5% B; 3–3.3 min – 95% B; 3.4–4.0 min – 5% B.
The MS system was equipped with electrospray ionization
source (ESI) operated in the negative-ion mode. ESI worked
at the following conditions: capillary temperature 300 C, cur-
tain gas at 40 psi, and nebulizer gas at 9 L/min. Nitrogen was
used as curtain and collision gas. For each compound the opti-
mum conditions of Multiple Reaction Mode (MRM) were
determined. Triplicate injections were made for each solution.
The analytes were identified by comparing retention time
(Rt 1.5 min) and [M]
+ at m/z 579.2 values obtained by MS
with the mass spectra from corresponding standards tested
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MRM mode were used for quantification of all analytes
(10 lM, 5 lM, 2.5 lM, 1.25 lM, 0.63 lM, 0.31 lM in 0.1 M
PBS/4.7% MeOH). As a positive control verapamil was used
(250 lM, 125 lM, 62.5 lM, 31.25 lM, 15.63 lM, 7.81 lM,
3.91 lM in 0.1 M PBS). The following formula was applied
to determine Pe:
Pe ð106 cm=sÞ ¼ Cx  lnð1 Cdrug acceptor=Cdrug equilibriumÞ;
where C ¼ Vdonor  Vacceptor=ðVdonor þ VacceptorÞ
 Time Peak areaTable 1 DPPH radical scavenging capacity of E. giraldii, E.
lasiogyne, eleutherosides E1, E and ascorbic acid.
Species EC50 [mg/mL]*[lg/mL]^
E. giraldii 0.18* ± 0.06
E. lasiogyne 0.17* ± 0.07
Eleutheroside E1 37.03^ ± 0.2
Eleutheroside E 5.40* ± 0.9
Ascorbic acid 41.0^ ± 0.052.7. Total phenolic content (TPC)
The total phenolic content of extracts was determined using
the method of Singleton and Rossi (1965). TPC was expressed
as gallic acid equivalents (20–100 lg/mL; y = 0.0026x
+ 0.044; r2 = 0.999; GAE/g dry extract). Every assay was per-
formed in triplicates.
2.8. Total flavonoid content (TFC)
The TFC in investigated samples was determined using alu-
minum chloride and 2,4-dinitrophrnylhydrazine colorimetric
methods (Chang et al., 2002). TFC were expressed as means
(±S.E.) mg of quercetin equivalent (QEs/g/dry sample for
FeCl3 method, 20–100 lg/mL; y= 0.0041x + 0.236;
r2 = 0.999) and as means (±S.E.) mg of hesperetin equivalent
(QEs/g/dry sample for 2,4-DNPH method, 250–1000 lg/mL;
y = 6.374x  0.098; r2 = 0.988). Every assay was performed
in triplicates.
2.9. HPTLC of eleutherosides B, E and E1
Chromatographic analysis was preceded by a clean-up proce-
dure, on C18 microcolumns, to purify the sample. To check
whether the eleutherosides were completely eluted from the
SPE microcolumns, the cartridges were flushed with 10 mL
75% ethanol. The HPTLC-densitometric examination of the
eluate, showed the absence of bands characteristic for the
investigated eleutherosides. It confirmed the complete yield
of eleutherosides from the microcolumns.
2.9.1. Polar adsorbent
The HPTLC analysis was done according to the chromato-
graphic method described by Załuski et al. (2010). Ethanolic
solutions of all standards (1 mg/mL, 1 lL) and plant extracts
(10 mg/mL, 3 lL) were used. After development, bands in
the extracts were identified by matching their Rf values and
UV scan with those obtained for standards.
2.9.2. Nonpolar adsorbent
The HPTLC analysis was done according to the method
described by Cieśla et al. (2011). Ethanolic solutions of all
standards (1 mg/mL, 1 lL) and plant extracts (10 mg/mL,
3 lL) were used. After development, bands in the extracts were
identified by matching their Rf values and UV scan with those
obtained for standards.2.10. HPTLC screening for antioxidants – direct bioautography
technique (HPTLC-DB)
The Si60 HPTLC-F254 and Si60 HPTLC RP18-WF254 plates
were developed according to the method described in the
HPTLC of eleutherosides B, E and E1 parts. After develop-
ment, the plates were dried at room temperature for 20 min.
and were dipped into the 0,5% methanolic solution of DPPH*
for 5 s. Active compounds appeared as yellow–white spots
against a purple background. White spots were visualized
under daily light after 1 min, 1, 10 and 24 h (Camag Visu-
aliser). Ethanolic solutions of standards (eleutheroside B, E
and E1; 1 mg/mL, 1 lL) and plant extracts (10 mg/mL, 3 lL)
were used.
2.11. Statistical analysis
All determinations were performed in triplicates. The obtained
data were subjected to statistical analysis using Statistica 7.0.
(StatSoft, Cracow). The evaluations were analyzed for one-
factor variance analysis. Statistical differences between the
treatment groups were estimated by Spearman’s (R) and Per-
son’s (r) test. All statistical tests were carried out at a signifi-
cance level of a = 0.05.
3. Results and discussion
3.1. Antioxidant properties
To our best knowledge, our study is the first to report the
antioxidant properties of eleutherosides B, E, E1, and E. giral-
dii and E. lasiogyne. The first step of the work was to establish
a change of absorbance in time. As is shown in Fig. 1 (Suppl.
Mat.), the optimal time is 30 min. which correlates with that of
the original method of this analysis. After this time no changes
in absorbance were noticed. On the basis of the obtained
results, all species were found to reduce the DPPH* radical
(Table 1). Both extracts have similar antioxidative activity
and the EC50 value ranged between 0.17 and 0.18 mg/mL for
E. lasiogyne and E. giraldii, respectively. The results for the
extracts were compared with the results for eleutherosides B,
E and E1 as naturally occurring compounds in the investigated
samples. Of the three eleutherosides, eleutheroside E1 exhib-
ited strong anti-DPPH* activity (EC50 37.03 lg/mL;
63 mMol), which was higher than ascorbic acid (41.0 lg/mL;
232 mMol).
524 D. Załuski et al.On the basis of statistical data, the correlation between
total phenolic content and radical scavenging activity was
revealed. It is in agreement with the general information on
polyphenols rich in hydroxyl group in C-3 or C-5 position in
the molecule.
3.2. The PAMPA test of eleutheroside E1 with LC/MS
detection
Permeability is one of the key parameters determining the
pharmacokinetic behavior of orally administered drugs. We
used PAMPA to study in vitro the absorption of eleutheroside
E1 and the nature of the mechanisms underlying passive trans-
port of eleutheroside E1, that still remain unclear. The perme-
ability classification is divided into three groups: low < 5;
moderate 5–20; and high > 20  106 cm/s. The chro-
matogram and spectra of eleutheroside E1 in the positive-
and negative-ion modes are shown in Fig. 2S, Suppl. Mat.
The Pe value for eleutheroside E1 was established as
0.5  106 cm/s, the recovery was 88.95%. The results
obtained indicate a low absorption of eleutheroside E1 with
a partial binding to the membrane. Verapamil was used as a
relatively high permeability compound (Pe 16.9  106 cm/s,
the recovery was 75.86%). It is worth noting that binding to
the membrane may influence the prolongation of eleutheroside
E1 time action, and its stimulating effect on the GALT. GALT
represents almost 70% of the human immune system, which is
stimulated by different molecules supplied to the body, not
always absorbable (Vighi et al., 2008). Our findings can explain
partially the adaptogenic activity of eleutheroside E1. Usually,
the researchers are focused on the activity of the crude extracts
and their stimulation effect on thymus and medulla, whereas
the influence of the extracts or eleutherosides on the GALT
activity still remains unexplained. Only one study reports on
the influence of the Eleutherococcus senticosus seeds extract
on the TLRs, in vitro. It has been demonstrated that the
extract may activate B cells and macrophages via the activa-
tion of TLR2 and/or TLR4 (Han et al., 2003). In other studies,
extracts from E. senticosus were used as adjuvants for vaccines
for the prevention and/or treatment of microbial, viral infec-
tions and/or cancer. It was suggested that they may affect
the expression of proteins associated with immune response
to microbial infection, viral infection and/or cancer. In further
studies, the PAMPA test should be modified with the use of
Caco-2 test to predict better bioavailability based on the active
transport. Further investigations are also needed to evaluate
its metabolism in vitro and clinical significance.
3.3. Antioxidative mechanism of eleutheroside action
On the basis of the obtained results, a relationship between the
structure of eleutherosides and their antioxidative activity was
established. Some authors have reported only a correlation
between DPPH* radical scavenging activity and total phenols
in the Eleutherococcus species, while the antioxidative mecha-
nism of action of their individual glycosides has not yet been
described. For this reason we have tried to explain the antirad-
ical action of these compounds (eleutherosides B, E, E1) and
we have proposed the mechanism by which these eleuthero-
sides may act as antioxidants. This was called ‘‘Załuski’s
eleutheroside hypothesis”. The interaction of potential antiox-idants with DPPH* depends on their structural conformation.
As it is known, antioxidant activity increases with the number
of OH groups on a given aromatic ring, but with no more than
three. Eleutherosides E and E1 are the glycosides of syringar-
esinol belonging to diphenols (furofuran lignans), while
eleutheroside B is the glycoside of syringing belonging to
monophenols (Fig. 1). In our test of eleutherosides E and
E1, only eleutheroside E1 showed strong antiradical proper-
ties. A close look at the structure of eleutheroside E1 and
eleutheroside E demonstrates the presence of one free OH
group in the phenyl ring of eleutheroside E1. In the case of
eleutheroside E, all of the OH groups are esterified by glucose
and do not participate in the reduction reaction. Fig. 2 shows
the suggested mechanism of the antiradical action of eleuthero-
side E1. In the structure of eleutheroside E1 there are four
methoxy groups (two in each aromatic ring) and the one free
OH group in the phenyl ring (Table 2).
According to the author’s hypothesis, the antioxidant
mechanism is based on the complexation of the DPPH* mole-
cule with the OH group of eleutheroside E1. During this reac-
tion, the aryl radical of eleutheroside E1 (E1*) and DPPHH
are created (Eq. (1)). Next, the aryl radical (E1*) is complexed
with another DPPH* molecule (Eq. (2)).
DPPH þ E1 $ DPPHHþ E1 ð1Þ
DPPH þ E1 $ DPPH E1 ð2Þ
Additionally, the aryl radical can be stabilized by the pres-
ence of the methoxy groups in the aromatic ring, which
increases its antioxidative action. Several authors have indi-
cated that the antioxidative properties depend on the number
of hydroxyl groups in the chemical formula, especially on
the OH group in the ortho and para positions. Eleutheroside
E1 has the one free OH group in the para position, which in
eleutheroside E is esterified by glucose. Additionally, the effec-
tiveness of radical scavenging is strengthened by the 3-OH
group attached to the 2,3-double bond. According to Pokorny,
the efficiency of the para diphenols is in part due to the stabi-
lization of the aryloxyl radical by hydrogen bonding or by
regeneration of another diphenol. This author has reported
that the presence of more than three hydroxyl groups on a
given aromatic nucleus did not improve the efficiency
(Brand-Williams et al., 1995; Chang et al., 2002; Vighi et al.,
2008; Pokorny, 1987). On the basis of the above findings, the
hypothesis seems to be true concerning the antioxidant activity
of eleutheroside E1. Moreover, the foregoing reasoning con-
firms that the anti-DPPH* activity of eleutherosides is in rela-
tion to their chemical structure and localization of the active
groups.
Among other eleutherosides, eleutheroside B was active in
the autography test, i.e. its yellow band was observed after
24 h from the immersion time. Taking into account the chem-
ical structure of eleutheroside B, we can see that eleutheroside
B has two OH groups. One of them is directly connected with
the aromatic ring and is esterified by glucose. The second, free
OH group is in the propenyl chain. The position and ability of
these groups is important. The lack of a free OH group directly
linked to the aromatic ring may be one of the causes for
weaker antioxidant properties. The second cause may be the
absence of the double C‚C bond by the carbon connected
with the OH group. Some authors believe that this bond
Figure 1 Chemical structure of eleutherosides B, E and E1.
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increases the antiradical efficiency (Cuvelier et al., 1992).
3.4. Total polyphenol and flavonoids content (TPC, TFC)
TPC was estimated using the Folin–Ciocalteu method and
expressed as a gallic acid equivalent (mg/g dry extract). As it
is shown in Table 3, both species contain the similar amount
of TPC (51.4 and 49.3 mg/g dry extract for E. giraldii and
E. lasiogyne, respectively). No data were found in the world lit-
erature. One of the most common procedures used to evaluate
the TFC is a spectrophotometric assay, based on the formation
of a complex between aluminum ion and the C-4 keto group
and either the C-3 or C-5 hydroxyl group of flavones and fla-
vonols. Besides, aluminum chloride forms acid labile com-
plexes with the ortho-dihydroxyl groups in the A- or B-ring
of flavonoids. The second procedure is also a spectrophoto-
metric assay, based on the reaction of 2,4-
dinitrophenylhydrazine (DNPH) with flavanones, forming
2,4-dinitrophenylhydrazones. The results obtained with the
use of these two methods were added up to evaluate the total
content of flavonoids. The summed amount of flavonoids was
5.7 and 4.9 mg/g dry extract for E. lasiogyne and E. giraldii,
respectively. We found that flavonoid content obtained by alu-
minum chloride reaction was much higher than those obtained
by DNPH reaction (Table 3). It can indicate, that the species
contain more compounds with the OH group which are
responsible for high antioxidant activity of extracts.3.5. HPTLC determination of eleutherosides B, E and E1
It is believed that eleutherosides B (syringing 4-b-D-glucoside),
E (()-syringaresinol-4,40-O-b-D-diglucoside), and E1 ((+)-syringaresinol-4-O-b-D-glucoside) are the main active com-
pounds in Eleutherococcus spp. According to Polish and Euro-
pean Pharmacopoeia, the roots should contain a minimum of
0.08% for the sum of eleutherosides B and E (Polish
Pharmacopoeia VIII, 2008; European Pharmacopoeia V,
2005). The chromatography of the eleutherosides was done
using the HPTLC technique as previously described by Załuski
et al. (Załuski et al., 2010; Cieśla et al., 2011). To ensure the
presence of the investigated eleutherosides in the samples, the
resolution of eleutherosides was performed using two station-
ary phases: Si60 HPTLC RP18-WF254 and Si60 HPTLC-
F254. After development, bands in the extracts were identified
by matching their Rf values and UV scan and spectra with
those obtained for the standards. Purity of the eleutheroside
peaks in all of the analyzed samples was examined by taking
the spectra at the peaks’ center and flanks (Fig. 3S, 4S; Suppl.
Mat.). As is shown in Fig. 3S, the investigated eleutherosides
are present in all samples. The results indicated that there
was no difference in the UV scan and spectra of each plant
sample and the standards. In the applied chromatographic sys-
tem, the eleutherosides are characterized by the following Rf
values: (nonpolar system): eleutheroside B-0.56, eleutheroside
E-0.46, eleutheroside E1-0.32; (polar system): eleutheroside
E-0.29; eleutheroside B-0.42, and eleutheroside E1-0.58. Data
in the literature indicates that eleutheroside E was detected
in E. giraldii growing in China (Wang and Sun, 2005). No
information on eleutherosides in E. lasiogyne was reported.
3.6. HPTLC-DPPH* test
The next step was to identify the free radical scavenging com-
pounds using the autography technique. Autography is a sim-
ple and rapid technique for the detection of the antioxidant
and radical scavenging properties of many plant samples.
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Figure 2 Potential mechanism of the reaction of DPPH* with eleutheroside E1.
Table 2 Localization of active groups in the tested
eleutherosides.
Eleutherosides Number
of free
OH groups
Substitution
position
Number of
OCH3 groups
E1 1 Para 2  2 (meta–meta)
E 0 – 2  2 (meta–meta)
B 1 Propene chain 2 (ortho)
Table 3 Total polyphenol and flavonoid content [mg/g dry
extract].
Species TPC Flavonoid content TFC
FeCl3 DNPH
E. giraldii 51.4 ± 0.5 4.8 ± 0.11 0.11 ± 0.04 4.91 ± 0.02
E. lasiogyne 49.3 ± 0.5 5.5 ± 0.08 0.17 ± 0.01 5.73 ± 0.03
526 D. Załuski et al.Regions of the TLC plate which contain DPPH* inhibitors
show up as yellow spots against a purple background. In the
present study yellow spots were observed after 1 min, 1, 10
and 24 h from the time of immersion of the plate in 0.5%
DPPH* solution. Eleutherosides B, E and E1 were used as nat-
ural compounds. All of the extracts showed areas of inhibitionof DPPH*. Four spots were noticed in the roots of E. giraldii
and three in the roots of E. lasiogyne after 1 min. In each of the
tracks on the chromatographic plate one additional spot was
detected after 24 h. After 1 min on the Si60 HPTLC-F254
plate, the first yellow spots were observed in extracts from
the roots at Rf 0.58 as well as in all of the extracts at Rf
0.37. A yellow-colored inhibitory substance was observed to
Figure 3 Bioautograph showing the DPPH* scavenging activity
after 1 min for standards: 1 – eleutheroside E1; ethanolic extracts
from: 2 – the roots E. giraldii, 3 – the roots E. lasiogyne.
HPTLC-profiling of eleutherosides 527migrate at the same Rf as eleutheroside E1 (Rf 0.58). It is note-
worthy that in the spectrophotometric assay, only eleuthero-
side E1 showed strong antiradical properties, and this was
confirmed in the autography test (Fig. 3).
No changes in decolorization of the chromatogram after 1
and 10 h were noticed. Additional yellow bands were observed
after 24 h. The Rf value was 0.42 and was the same as for
eleutheroside B. Yellow bands were not observed at a high
Rf for eleutheroside E. Using the Si60 HPTLC RP18-WF254
plate, the first yellow spot was observed in extracts from the
roots at Rf 0.32, and this was the same Rf as for eleutheroside
E1. Other yellow bands were observed at a high Rf of 0.15; 0.5
and 0.61. New yellow bands were not determined after 1, 10
and 24 h.
4. Conclusions
One way of evaluating the adaptogenic activity of natural
compounds is to determine their ability to reduce DPPH*.
On the basis of the obtained results, such properties of the
extracts have been observed. In addition, several single com-
pounds of the extract have anti-DPPH* activity, such as
eleutheroside E1 and E in the spectrophotometric test and
eleutheroside B and E1 in the autography test. E. giraldii
and E. lasiogyne are a promising, natural source of the chem-
ical substances with antioxidant properties, eg. eleutheroside
E1. To support the hypothesis, it would be worth to character-
ize the reaction products using LC/MS in order to determine
intermediate antiradical compounds, as well to quantify
eleutheroside E1 in those roots.
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Cieśla, Ł., Kryszeń, J., Stochmal, A., Oleszek, W., Waksmundzka-
Hajnos, M., 2012. Approach to develop a standardized TLC-
DPPH test for assessing free radical scavenging properties of
selected phenolic compounds. J. Pharm. Biomed. Anal. 70, 126–
135.
Cooke, M.S., 2012. Special issue on DNA oxidation: mechanisms,
measurement and consequences. Free Radical Res. 46, 365–366.
Cuvelier, M.E., Richard, H., Berset, C., 1992. Comparison of the
antioxidative activity of some acid-phenols: structure–activity
relationship. Biosci. Biotechnol. Biochem. 56, 324–325.
Deng, H.Z., Hou, L.B., Sun, S.Y., Li, S.Y., 1994. An experimental
study on the effect of Acanthopanax giraldii harms on the central
nervous system. China J. Chin. Materia Medica 19, 171–174.
Dong-Liang, Ch., Yu, S., Li, Y., 1994. Triterpene glycosides in the
leaves of Acanthopanax giraldii. Acta Bot. Sin. 36, 75–79.
European Pharmacopoeia V, 2005. Council of Europe, Strasbourg,
France. pp. 1497–1499.
Feng, S., Hu, F., Zhao, J., 2006. Determination of eleutheroside E and
eleutheroside B in rat plasma and tissue by high-performance liquid
chromatography using solid-phase extraction and photodiode
array detection. Eur. J. Pharm. Biopharm. 62, 318–319.
Han, S.B., Yoon, Y.D., Ahn, H.J., Lee, H.S., Lee, C.W., Yoon, W.K.,
Park, S.K., Kim, H.M., 2003. Toll-like receptor-mediated activa-
tion of B cells and macrophages by polysaccharide isolated from
cell culture of Acanthopanax senticosus. Inter. Immunopharm. 3,
1301–1312.
Li, Y., Yuan, W., Liu, C., 2009. Determination of isofraxidin from
Acanthopanax giraldii by RPHPLC. Lishizhen Med. Materia
Medica Res. [online].
Liu, Y., Meng, Q., Ren, Ch., 2007. RP – HPLC determination of
adenosine in Acanthopanax giraldii (Tibetan drug) produced from
different regions of Sichuan. Chin. J. Pharm. Anal. (Abstr. Engl.).
Park, H., Park, E., Rim, A., 2006. Antioxidant activity of extracts
from Acanthopanax senticosus. Afr. J. Biotech. 5, 2388–2396.
Pokorny, J., 1987. In: Chan, H. (Ed.), Autoxidation of Unsaturated
Lipids. Academic Press, London (141–20).
Polish Pharmacopoeia VIII, 2008. The Office for Registration of
Medicinal Products, Medical Devices and Biological Products,
Warsaw, Poland, 2, 1625–1627.
Singleton, V.L., Rossi, J.A., 1965. Colometry of total phenolics with
phosphomolybdic-phospotungstic acid reagents. Am. J. Enol.
Vitic. 16, 144–158.
Tumiłowicz, J., Banaszczak, P., 2007. Trees and shrubs of aquifoli-
aceae family in rogów glinna arboreta. Rocznik Dendrologiczny
55, 41–56 (in polish).
528 D. Załuski et al.Vighi, G., Marcucci, F., Sensi, L., Cara, G., Frati, F., 2008. Allergy
and the gastrointestinal system. Clin. Exp. Immun. 153, 3–6.
Wang, Z., Sun, Y., 2005. Rapid analysis of the stem bark of
Acanthopanax giraldii harms by HPLC/DAD/ESI/MS. J. Liq.
Chromatogr. 28, 1291–1298.
Wang, J.Z., Tsumura, H., Shimura, K., Ito, H., 1992. Antitumor
activity of polysaccharide from a Chinese medicinal herb Acan-
thopanax giraldii harms. Cancer Lett. 65, 79–84.
Wang, Z., Hang, L., Sun, Y., 2005. Semipreparative separation and
determination of eleutheroside E in Acanthopanax giraldii harms by
high-performance liquid chromatography. J. Chromatogr. Sci. 43,
249–252.
Yuan, F., Chen, J., Xu, J., Zheng, J., Chin, Q., 2009. Antiinflamma-
tory mechanism of total glycosides of Acanthopanax giraldii. J.
Integr. Med. 15, 210–215.Załuski, D., Smolarz, H.D., Chomicki, A., 2010. TLC screening for
eleutherosides B, E, and E1, and isofraxidin in the roots of six
Eleutherococcus species cultivated in Poland. Acta Chromatogr. 22,
581–589.
Załuski, D., Smolarz, H.D., Szpilewska, M., 2011. Eleutherosides in
aerial parts of Eleutherococcus species cultivated in Poland.
JAOAC 94, 1422–1426.
Załuski, D., Mendyk, E., Smolarz, H.D., 2016. Identification of MMP-
1 and MMP-9 inhibitors from the roots of Eleutherococcus
divaricatus, and the PAMPA test. Nat. Prod. Res. 30, 595–599.
Zhao, Y., Yuan, C., 1991. Chemical constituents of Acanthopanax
giraldii harms. China J. Chin. Materia Medica 16, 421–424.
